The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

Our previous studies have demonstrated that sorafenib can promote the dissemination of hepatocellular carcinoma (HCC) through downregulation of HTATIP2, a suppressor of tumor growth and metastasis that is associated with inhibition of angiogenesis. Here, we investigated the predictive values of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Sun, Hui-Chuan, Wu, Chun-Tao, Zhu, Xiao-Dong, Zhang, Wei, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Tang, Zhao-You, Yu, Xian-Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116529/
https://ncbi.nlm.nih.gov/pubmed/25008315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados